MARÍA
HERNÁNDEZ SÁNCHEZ
Investigadora no período 2013-2017
Universidad Complutense de Madrid
Madrid, EspañaPublicacións en colaboración con investigadores/as de Universidad Complutense de Madrid (18)
2024
-
Characterization of Human B Cell Hematological Malignancies Using Protein-Based Approaches
International Journal of Molecular Sciences, Vol. 25, Núm. 9
2023
-
A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions
Cancer Genetics, Vol. 272-273, pp. 16-22
-
Editorial: Multi-omics data integration: key to thoroughly understanding the immune system
Frontiers in Cell and Developmental Biology
-
Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing
STAR Protocols, Vol. 4, Núm. 4
-
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
Blood cancer discovery, Vol. 4, Núm. 2, pp. 150-169
-
Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models
Blood Advances, Vol. 7, Núm. 16, pp. 4514-4517
2022
-
High-Throughput CRISPR Screening in Hematological Neoplasms
Cancers, Vol. 14, Núm. 15
-
TRAF3 alterations are frequent in del-3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features
American Journal of Hematology, Vol. 97, Núm. 7, pp. 903-914
-
Uso de las redes sociales Twitter e Instagram como herramientas docentes para la enseñanza de la genética clínica en la Universidad de Salamanca
La necesidad de la transformación social desde la innovación docente y educativa (Aula Magna), pp. 261-279
2021
-
From biomarkers to models in the changing landscape of chronic lymphocytic leukemia: Evolve or become extinct
Cancers, Vol. 13, Núm. 8
-
The evolving landscape of chronic lymphocytic leukemia on diagnosis, prognosis and treatment
Diagnostics, Vol. 11, Núm. 5
2020
-
Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?
Clinical Lymphoma, Myeloma and Leukemia, Vol. 20, Núm. 8, pp. 548-555.e4
2018
-
Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia
Leukemia and Lymphoma, Vol. 59, Núm. 3, pp. 633-642
-
The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers only Prognostic Model and the MD Anderson Cancer Center Prognostic Index
BioMed Research International, Vol. 2018
2017
-
Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL
European Journal of Haematology, Vol. 98, Núm. 2, pp. 142-148
2016
-
A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia
Hematological Oncology, Vol. 34, Núm. 2, pp. 84-92
2015
-
MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL
BMC Cancer, Vol. 15, Núm. 1
2014
-
Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia
BioMed Research International, Vol. 2014